Status:
COMPLETED
TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolaemia
Hyperlipidaemia
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
In patients with primary hypercholesterolemia treated with a statin and with ldl-c above the recommended target goal (esc 2003 recommendations ldl\>=1.15 g/l) to compare the efficacy and the safety of...
Eligibility Criteria
Inclusion
- Primary hypercholesterolemia treated with any statin at any dose, for at least 3 months with a ldl cholesterol above 115 mg/dl (esc 2003 recommendations).
Exclusion
- pregnant or breast feeding women
- Lipid-lowering agents including hmg-coa reductase inhibitors other than the current statin, fish oils, cholestyramin, niacin (\>200 mg/day) and fibrates taken within the 3 months preceding visit 1.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
1496 Patients enrolled
Trial Details
Trial ID
NCT00328523
Start Date
June 1 2004
End Date
January 1 2006
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.